Showing results (1-10 of 165) with videos related to
Sort By:
Pageof 17
Ophthalmology Science|November 29, 2023
Evaluation of Publications from the American Academy of Ophthalmology: A 5-Year Analysis of Ophthalmology LiteratureFritz Gerald P Kalaw, Kiana Tavakoli, Sally L BaxterJournal of Glaucoma|December 10, 2025
Associations Between Physical Activity and Glaucoma: Analysis of the National Institutes of Health All of Us Research ProgramPatrick Akarapimand, Shahin Hallaj, Robert N Weinreb, et al.Translational Vision Science & Technology|February 20, 2024
Disparities in Eye Care Utilization Among Refugee and Migrant PopulationsIvan A Copado, Shahin Hallaj, Bharanidharan Radha Saseendrakumar, et al.Journal of Glaucoma|March 20, 2024
Novel Technologies in Artificial Intelligence and Telemedicine for Glaucoma ScreeningMark Christopher, Shahin Hallaj, Anuwat Jiravarnsirikul, et al.Ophthalmology. Glaucoma|June 20, 2024
Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle GlaucomaKiana Tavakoli, Sophia Sidhu, Bharanidharan Radha Saseendrakumar, et al.Ophthalmology Science|July 14, 2023
Concept Coverage Analysis of Ophthalmic Infections and Trauma among the Standardized Medical Terminologies SNOMED-CT, ICD-10-CM, and ICD-11Kiana Tavakoli, Fritz Gerald P Kalaw, Sonali Bhanvadia, et al.Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure ChangeShahin Hallaj, William Halfpenny, Benton G Chuter, et al.Research Square|November 24, 2025
Multi-Ancestry Genome-Wide Association Study in All of Us for Primary Open- Angle GlaucomaKiana Tavakoli, Bonnie B Huang, Tara Mirmira, et al.American Journal of Ophthalmology|September 5, 2024
Association Between Glucagon-Like Peptide-1 Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure ChangeShahin Hallaj, William Halfpenny, Benton G Chuter, et al.Ophthalmology. Retina|June 2, 2026
Glucagon Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration IncidenceShahin Hallaj, Takashi Nishida, Alireza Kamalipour, et al.Pageof 17